Literature DB >> 21555913

Inflammasome-mediated suppression of inflammation-induced colorectal cancer progression is mediated by direct regulation of epithelial cell proliferation.

Bo Hu1, Eran Elinav, Richard A Flavell.   

Abstract

Chronic inflammation is a risk factor for many types of human cancers, yet the precise mechanism of this strong association is largely unknown. The inflammasome is a multiprotein complex that has recently been shown to orchestrate multiple innate and adaptive immune responses, yet its potential role in inflammation-induced cancer has been little studied. We recently reported a surprising link between the inflammasome and colorectal inflammation-induced tumorigenesis. In the model, the role of caspase-1 and NLRC4 in tumorigenesis was found to be mediated by direct and profound effects on colonic epithelial cell proliferation and cell death, rather than through regulation of colonic inflammation. Herein, we discuss the recent advances and discoveries related to the role of inflammasome in inflammation-induced colorectal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21555913     DOI: 10.4161/cc.10.12.16008

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  25 in total

Review 1.  Inflammasomes in intestinal inflammation and cancer.

Authors:  Grace Y Chen; Gabriel Núñez
Journal:  Gastroenterology       Date:  2011-10-15       Impact factor: 22.682

Review 2.  Inflammation and colorectal cancer: colitis-associated neoplasia.

Authors:  Sergei I Grivennikov
Journal:  Semin Immunopathol       Date:  2012-11-16       Impact factor: 9.623

3.  An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer.

Authors:  Zhenshu Wen; Zhi-Ping Liu; Zhengrong Liu; Yan Zhang; Luonan Chen
Journal:  J Am Med Inform Assoc       Date:  2012-09-11       Impact factor: 4.497

4.  Inflammasome expression and cytomegalovirus viremia in critically ill patients with sepsis.

Authors:  Nina Singh; Makoto Inoue; Ryosuke Osawa; Marilyn M Wagener; Mari L Shinohara
Journal:  J Clin Virol       Date:  2017-05-18       Impact factor: 3.168

Review 5.  Nucleic acid sensing pattern recognition receptors in the development of colorectal cancer and colitis.

Authors:  Liangmei He; Yayun Chen; Yuanbing Wu; Ying Xu; Zixiang Zhang; Zhiping Liu
Journal:  Cell Mol Life Sci       Date:  2017-02-21       Impact factor: 9.261

6.  Interactome-wide analysis identifies end-binding protein 1 as a crucial component for the speck-like particle formation of activated absence in melanoma 2 (AIM2) inflammasomes.

Authors:  Li-Jie Wang; Chia-Wei Hsu; Chiu-Chin Chen; Ying Liang; Lih-Chyang Chen; David M Ojcius; Ngan-Ming Tsang; Chuen Hsueh; Chih-Ching Wu; Yu-Sun Chang
Journal:  Mol Cell Proteomics       Date:  2012-08-06       Impact factor: 5.911

Review 7.  NLRP3 inflammasome in colitis and colitis-associated colorectal cancer.

Authors:  Agampodi Promoda Perera; Karishma Sajnani; Joanne Dickinson; Rajaraman Eri; Heinrich Körner
Journal:  Mamm Genome       Date:  2018-09-11       Impact factor: 2.957

Review 8.  Beneficial and Detrimental Roles of NLRs in Carcinogenesis.

Authors:  Ann M Janowski; Ryan Kolb; Weizhou Zhang; Fayyaz S Sutterwala
Journal:  Front Immunol       Date:  2013-11-12       Impact factor: 7.561

Review 9.  Inflammasomes in cancer: a double-edged sword.

Authors:  Ryan Kolb; Guang-Hui Liu; Ann M Janowski; Fayyaz S Sutterwala; Weizhou Zhang
Journal:  Protein Cell       Date:  2014-01-29       Impact factor: 14.870

Review 10.  Emerging Concepts about NAIP/NLRC4 Inflammasomes.

Authors:  Silvia Lucena Lage; Carla Longo; Laura Migliari Branco; Thaís Boccia da Costa; Carina de Lima Buzzo; Karina Ramalho Bortoluci
Journal:  Front Immunol       Date:  2014-07-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.